Frazier Life Sciences Management, L.P.
CIK 1892134 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $4.6B
- Posisi
- 41
- Per tanggal
- 30 Juni 2026
#857 dari 9.443 berdasarkan nilai 13F · top 9.1%
Nilai portofolio QoQ: +18.2% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 73,61%
- Bobot 25 kepemilikan teratas
- 93,39%
- Posisi di atas 1%
- 22
- Jumlah posisi efektif
- 11,8
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 7,98% Perkiraan pembelian $338.273.394 · penjualan $349.584.619
Kepemilikan median: 4,0 kuartal Dilacak Q4 2024–Q2 2026 · 51,9% masih dipegang
- Posisi baru
- 6
- Meningkat
- 8
- Menurun
- 2
- Tertutup
- 3
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
Kinerja vs S&P 500
Tahunan: +68.8% · S&P 500: +18.0%
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 96,9% · Opsi dikecualikan: 0,0%
Rincian sektor
Healthcare
98,0%
Lainnya/Tidak terpetakan
2,0%
Portofolio lengkap 41 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| MIRM Mirum Pharmaceuticals, Inc. - common stock | $899.060.606 | 19,58% | 7.679.684 | $189.611.398 | |||
| NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | $613.032.889 | 13,35% | 18.088.902 | $70.662.683 | Naik ×1 | ||
| ERAS Erasca, Inc. - Common Stock | $457.545.444 | 9,96% | 24.975.188 | $58.300.902 | Naik ×2 | ||
| MBX MBX Biosciences, Inc. - Common Stock | $367.191.118 | 8,00% | 6.652.013 | $168.628.530 | |||
| ARQT Arcutis Biotherapeutics, Inc. - Common stock | $258.909.678 | 5,64% | 9.874.511 | $26.266.199 | |||
| TRVI Trevi Therapeutics, Inc. - Common Stock | $185.370.687 | 4,04% | 9.939.447 | $66.791.891 | Turun ×2 | ||
| KRYS Krystal Biotech, Inc. - Common Stock | $178.887.373 | 3,90% | 481.307 | $54.556.149 | |||
| MAZE Maze Therapeutics, Inc. - Common Stock | $150.182.184 | 3,27% | 5.032.915 | $13.849.055 | Naik ×1 | ||
| PHAT Phathom Pharmaceuticals, Inc. - Common Stock | $135.261.406 | 2,95% | 12.466.489 | $-3.241.287 | |||
| PVLA Palvella Therapeutics, Inc. - Common Stock | $134.848.368 | 2,94% | 882.400 | $24.857.208 | |||
| BBIO BridgeBio Pharma, Inc. - Common Stock | $115.305.393 | 2,51% | 1.548.139 | $-140.753.409 | Turun ×3 | ||
| IRON Disc Medicine, Inc. - Common Stock | $99.093.875 | 2,16% | 1.354.852 | $12.464.638 | |||
| CYTK Cytokinetics, Incorporated - Common Stock | $98.810.092 | 2,15% | 1.159.879 | $22.362.467 | |||
| DYN Dyne Therapeutics, Inc. - Common Stock | $70.029.951 | 1,53% | 3.153.082 | $12.864.574 | |||
| ASND Ascendis Pharma A/S - American Depositary Shares | $60.053.342 | 1,31% | 225.155 | $29.556.085 | Naik ×1 | ||
| SVRA Savara, Inc. - Common Stock | $59.880.448 | 1,30% | 9.720.852 | $6.804.596 | |||
| Penerbit tidak dikenal (CUSIP: 698955101) | $52.572.433 | 1,14% | 1.920.805 | Naik ×1 | |||
| AURA Aura Biosciences, Inc. - Common Stock | $50.410.000 | 1,10% | 7.100.000 | $16.291.000 | Naik ×1 | ||
| ACHV Achieve Life Sciences, Inc. - Common Shares | $49.724.879 | 1,08% | 7.614.836 | Naik ×1 | |||
| VOR Vor Biopharma Inc. - Common Stock | $46.833.917 | 1,02% | 2.543.939 | $1.450.045 | |||
| ALLO Allogene Therapeutics, Inc. - Common Stock | $46.689.069 | 1,02% | 22.446.668 | $37.425.199 | Naik ×1 | ||
| TARS Tarsus Pharmaceuticals, Inc. - Common Stock | $45.860.853 | 1,00% | 728.644 | $-5.253.524 | |||
| BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | $40.092.400 | 0,87% | 4.009.240 | $1.924.435 | |||
| ALKS Alkermes plc - Ordinary Shares | $36.710.400 | 0,80% | 700.647 | $11.935.522 | |||
| ACAD ACADIA Pharmaceuticals Inc. - Common Stock | $36.386.409 | 0,79% | 1.438.198 | $4.372.122 | |||
| ZLAB Zai Lab Limited - American Depositary Shares | $36.144.080 | 0,79% | 1.902.320 | $361.441 | |||
| MNKD MannKind Corporation - Common Stock | $28.116.000 | 0,61% | 6.600.000 | $13.661.000 | Naik ×2 | ||
| DSGN Design Therapeutics, Inc. - Common Stock | $26.188.587 | 0,57% | 1.809.854 | ||||
| ACRS Aclaris Therapeutics, Inc. - Common Stock | $26.055.228 | 0,57% | 4.925.374 | $7.585.075 | |||
| STTK Shattuck Labs, Inc. - Common Stock | $26.025.000 | 0,57% | 3.750.000 | Naik ×1 | |||
| Penerbit tidak dikenal (CUSIP: 482931102) | $24.233.000 | 0,53% | 1.100.000 | Naik ×1 | |||
| GLUE Monte Rosa Therapeutics, Inc. - Common Stock | $24.200.000 | 0,53% | 1.000.000 | $7.750.000 | |||
| LXEO Lexeo Therapeutics, Inc. - Common Stock | $22.459.095 | 0,49% | 4.824.725 | $-2.938.827 | Naik ×1 | ||
| RLAY Relay Therapeutics, Inc. - Common Stock | $19.003.616 | 0,41% | 1.015.693 | Naik ×1 | |||
| EOLS Evolus, Inc. - Common Stock | $18.256.815 | 0,40% | 2.630.665 | $7.444.782 | |||
| IMCR Immunocore Holdings plc - American Depositary Shares | $15.391.829 | 0,34% | 484.782 | $775.652 | |||
| VALN Valneva SE - American Depositary Shares | $11.985.413 | 0,26% | 2.291.666 | $-2.337.500 | |||
| NAMSW NewAmsterdam Pharma Company N.V. - Warrant | $10.692.116 | 0,23% | 500.333 | $665.443 | |||
| AUTL Autolus Therapeutics plc - American Depositary Shares | $7.116.656 | 0,15% | 4.447.910 | $978.540 | |||
| Penerbit tidak dikenal (CUSIP: 98422T209) | $4.047.598 | 0,09% | 422.505 | $494.331 | |||
| IBIO iBio, Inc. - Common Stock | $3.418.567 | 0,07% | 1.953.467 | $-293.020 | |||
| Tidak ada hasil | |||||||
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
| Sekuritas | Nilai | Saham | % dari portofolio |
|---|---|---|---|
| Penerbit tidak dikenal (CUSIP: 698955101) | $52.572.433 | 1.920.805 | 1,14% |
| ACHV | $49.724.879 | 7.614.836 | 1,08% |
| DSGN | $26.188.587 | 1.809.854 | 0,57% |
| STTK | $26.025.000 | 3.750.000 | 0,57% |
| Penerbit tidak dikenal (CUSIP: 482931102) | $24.233.000 | 1.100.000 | 0,53% |
| RLAY | $19.003.616 | 1.015.693 | 0,41% |
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| MIRM | Hanya pergerakan harga | +0 | +$189.6M |
| MBX | Hanya pergerakan harga | +0 | +$168.6M |
| BBIO | Dipangkas | -1.9M | -$140.8M |
| NAMS | Beli lebih banyak | +1.1M | +$70.7M |
| TRVI | Dipangkas | -100 | +$66.8M |
| ERAS | Beli lebih banyak | +300K | +$58.3M |
| KRYS | Hanya pergerakan harga | +0 | +$54.6M |
| ASND | Beli lebih banyak | +92K | +$29.6M |
| ARQT | Hanya pergerakan harga | +0 | +$26.3M |
| PVLA | Hanya pergerakan harga | +0 | +$24.9M |
1 posisi disembunyikan (pemeriksaan kelengkapan data)
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| VRNA | 31 Des. 2025 | 3.383.950 | $361.101.305 | Tidak lagi dilacak |
| KALV | 30 Juni 2026 | 4.961.108 | $99.867.104 | Tidak lagi dilacak |
| RNA | 31 Maret 2026 | 983.125 | $70.912.806 | -1,6% |
| RVMD | 30 Juni 2026 | 675.686 | $65.710.464 | 16,4% |
| ABVX | 31 Maret 2026 | 378.300 | $51.015.647 | 7,8% |
| AGIO | 30 Juni 2026 | 1.256.080 | $42.493.186 | -4,5% |
| RYTM | 30 Juni 2025 | 678.760 | $35.953.917 | 86,0% |
| SLNO | 30 Juni 2025 | 499.159 | $35.664.911 | Tidak lagi dilacak |
| EWTX | 31 Maret 2025 | 1.271.245 | $33.942.242 | 110,1% |
| RAPT | 31 Maret 2026 | 983.333 | $33.305.489 | Tidak lagi dilacak |
| RARE | 31 Des. 2025 | 983.715 | $29.590.147 | 14,8% |
| HLVX | 30 Sep. 2025 | 10.617.062 | $21.127.953 | Tidak lagi dilacak |
| ANAB | 31 Maret 2025 | 1.573.719 | $20.836.040 | 220,8% |
| CGON | 30 Sep. 2025 | 770.000 | $20.020.000 | 94,8% |
| MREO | 31 Des. 2025 | 9.440.112 | $19.446.631 | -26,5% |
| AKRO | 31 Des. 2025 | 366.784 | $17.414.904 | Tidak lagi dilacak |
| PCVX | 31 Des. 2025 | 474.405 | $17.088.068 | 34,9% |
| MRUS | 30 Juni 2025 | 373.100 | $15.703.779 | Tidak lagi dilacak |
| PLRX | 31 Maret 2025 | 1.120.803 | $14.760.976 | -12,2% |
| COGT | 30 Sep. 2025 | 1.734.601 | $12.454.435 | 162,0% |
| JBIO | 31 Des. 2025 | 1.413.280 | $12.196.606 | 50,4% |
| ASMB | 31 Des. 2025 | 456.249 | $11.679.974 | -3,4% |
| ORIC | 30 Sep. 2025 | 1.065.334 | $10.813.140 | 19,6% |
| ADVM | 31 Des. 2025 | 2.077.431 | $9.410.762 | Tidak lagi dilacak |
| TVTX | 31 Maret 2026 | 241.592 | $9.231.230 | 118,5% |
| DAWN | 31 Maret 2025 | 689.655 | $8.737.929 | Tidak lagi dilacak |
| ENGN | 31 Des. 2025 | 1.157.380 | $7.904.905 | -80,6% |
| ETNB | 31 Maret 2025 | 1.000.000 | $7.820.000 | Tidak lagi dilacak |
| ACAD | 30 Juni 2025 | 470.338 | $7.812.314 | 42,1% |
| RCKT | 30 Juni 2025 | 1.079.025 | $7.197.097 | 44,7% |
| ORKA | 30 Sep. 2025 | 583.327 | $6.539.096 | 469,6% |
| IMTX | 30 Juni 2025 | 1.247.911 | $5.628.079 | 71,6% |
| ARVN | 31 Maret 2025 | 285.331 | $5.469.795 | 36,6% |
| MGNX | 31 Des. 2025 | 3.175.665 | $5.335.117 | 159,3% |
| SLN | 31 Des. 2025 | 970.130 | $5.034.975 | 131,3% |
| DSGN | 31 Maret 2026 | 521.000 | $4.886.980 | 50,5% |
| ELDN | 31 Maret 2025 | 1.176.735 | $4.848.148 | 7,7% |
| XLO | 31 Maret 2026 | 5.915.091 | $3.786.841 | 10,5% |
| CBIO | 31 Des. 2025 | 272.951 | $3.245.387 | 46,7% |
| ELEV | 30 Sep. 2025 | 5.993.579 | $2.200.243 | Tidak lagi dilacak |